World’s First Engineered T Cell Receptor Trial Opens With new Cellular Therapy for HIV

News   Oct 12, 2009

 
World’s First Engineered T Cell Receptor Trial Opens With new Cellular Therapy for HIV
 
 
 

RELATED ARTICLES

Drug Discovery Alliance Formed to Help Increase Drug Development Success Rate

News

Two prominent preclinical safety companies have launched a unique European alliance to address the high safety-related failure rate in drug development.

READ MORE

First Ever Online Event Focused on Cannabis Science

News

Analytical Cannabis is pleased to announce that the final line-up of speakers for the first ever cannabis science online event, The Science of Cannabis 2017 has been confirmed.

READ MORE

Discovery Provides Hope for New Vaccine Against Flesh-eating Bacteria

News

Researchers at Houston Methodist have solved a 100-year-old mystery, providing them a possible key to unlock a pathway for treating diseases caused by flesh-eating bacteria.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE